+Search query
-Structure paper
Title | Discovery of Roblitinib (FGF401) as a Reversible-Covalent Inhibitor of the Kinase Activity of Fibroblast Growth Factor Receptor 4. |
---|---|
Journal, issue, pages | J. Med. Chem., Vol. 63, Page 12542-12573, Year 2020 |
Publish date | Apr 1, 2020 (structure data deposition date) |
Authors | Fairhurst, R.A. / Knoepfel, T. / Buschmann, N. / Leblanc, C. / Mah, R. / Todorov, M. / Nimsgern, P. / Ripoche, S. / Niklaus, M. / Warin, N. ...Fairhurst, R.A. / Knoepfel, T. / Buschmann, N. / Leblanc, C. / Mah, R. / Todorov, M. / Nimsgern, P. / Ripoche, S. / Niklaus, M. / Warin, N. / Luu, V.H. / Madoerin, M. / Wirth, J. / Graus-Porta, D. / Weiss, A. / Kiffe, M. / Wartmann, M. / Kinyamu-Akunda, J. / Sterker, D. / Stamm, C. / Adler, F. / Buhles, A. / Schadt, H. / Couttet, P. / Blank, J. / Galuba, I. / Trappe, J. / Voshol, J. / Ostermann, N. / Zou, C. / Berghausen, J. / Del Rio Espinola, A. / Jahnke, W. / Furet, P. |
External links | J. Med. Chem. / PubMed:32930584 |
Methods | X-ray diffraction |
Resolution | 2.13 Å |
Structure data | PDB-6yi8: |
Chemicals | ChemComp-FGF: ChemComp-SO4: ChemComp-HOH: |
Source |
|
Keywords | TRANSFERASE / TYROSINE KINASE INHIBITOR / COVALENT REVERSIBLE INHIBITOR / FGFR4 / ROBLITINIB |